Fulgent Genetics, Inc. — Director's Dealing 2023

Feb 27, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2023-02-23

Reporting Person: KIM PAUL (CFO and Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-23	Common Stock	A	2142	$0.00	Acquired	223185	Direct
2023-02-23	Common Stock	A	14218	$0.00	Acquired	237403	Direct
2023-02-23	Common Stock	F	741	$31.65	Disposed	236662	Direct

Footnotes

F1: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022.

F2: Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after February 23, 2023, and 1/12th of such shares vesting at the end of every three month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.

F3: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022.